World's Best Scientists 2026 revealed!
James F. Markmann

James F. Markmann

D-Index & Metrics

Medicine

D-Index
83
Citations
23606
World Ranking
15681
National Ranking
7890

Overview

James F. Markmann is affiliated with Harvard University in the United States. Their research primarily focuses on medicine, with significant contributions to fields such as surgery, hepatology, immunology, public health, environmental and occupational health, and transplantation.

Their work spans a range of topics related to organ transplantation and disease management including:

  • Organ Transplantation Techniques and Outcomes
  • Liver Disease and Transplantation
  • Organ Donation and Transplantation
  • Renal Transplantation Outcomes and Treatments
  • Pancreatic Function and Diabetes
  • Xenotransplantation and Immune Response
  • Diabetes Management and Research

Markmann has published extensively in several key journals, with frequent appearances in:

  • American Journal of Transplantation
  • Transplantation
  • Transplantation Direct
  • Liver Transplantation
  • Diabetes

Frequent collaborators include Heidi Yeh, Korkut Uygun, Anil Kharga, Alban Longchamp, and Shoko Kimura.

Among their recent papers are:

  • Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials, 2020, The Lancet
  • Impact of Portable Normothermic Blood-Based Machine Perfusion on Outcomes of Liver Transplant, 2022, JAMA Surgery
  • Design and testing of a humanized porcine donor for xenotransplantation, 2023, Nature
  • Extensive germline genome engineering in pigs, 2020, Nature Biomedical Engineering
  • Expanding controlled donation after the circulatory determination of death: statement from an international collaborative, 2021, Intensive Care Medicine

Best Publications

  • Therapeutic siRNA silencing in inflammatory monocytes in mice

    Florian Leuschner;Partha Dutta;Rostic Gorbatov;Tatiana I Novobrantseva

  • Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia

    Bernhard J. Hering;William R. Clarke;Nancy D. Bridges;Thomas L. Eggerman

  • Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin.

    Jay S. Markowitz;Paul Martin;Andrew J. Conrad;James F. Markmann

  • The promise of organ and tissue preservation to transform medicine

    Sebastian Giwa;Jedediah K Lewis;Luis Alvarez;Luis Alvarez;Luis Alvarez;Robert Langer

  • Induction of donor-specific unresponsiveness by intrathymic islet transplantation

    Andrew M. Posselt;Clyde F. Barker;John E. Tomaszewski;James F. Markmann

  • Homeostatic proliferation is a barrier to transplantation tolerance

    Zihao Wu;Steven J Bensinger;Jidong Zhang;Chuangqi Chen

  • Survival Following Liver Transplantation From Non-Heart-Beating Donors

    Peter L. Abt;Niraj M. Desai;Michael D. Crawford;Lisa M. Forman

  • Structural and Functional Abnormalities in the Islets Isolated From Type 2 Diabetic Subjects

    Shaoping Deng;Marko Vatamaniuk;Xiaolun Huang;Nicolai Doliba

  • Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications.

    Peter Abt;Michael Crawford;Niraj Desai;James Markmann

  • ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation.

    D. J. Reich;D. C. Mulligan;P. L. Abt;T. L. Pruett

  • Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.

    Birgit Sawitzki;Paul N Harden;Petra Reinke;Aurélie Moreau

  • Antigen presenting function of class II MHC expressing pancreatic beta cells

    James Markmann;David Lo;Ali Naji;Richard D. Palmiter

  • Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function.

    Niraj M. Desai;Kevin C. Mange;Michael D. Crawford;Peter L. Abt

  • TGF-β-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance

    Kang Mi Lee;Ryan T Stott;Gaoping Zhao;Gaoping Zhao;Julie SooHoo

  • Long-term survival after retransplantation of the liver.

    James F. Markmann;Jay S. Markowitz;Hasan Yersiz;Marcia Morrisey

  • Subnormothermic machine perfusion for ex vivo preservation and recovery of the human liver for transplantation

    B. G. Bruinsma;B. G. Bruinsma;H. Yeh;S. Ozer;Paulo N.A. Martins

  • Insulin independence following isolated islet transplantation and single islet infusions.

    James F. Markmann;Shaoping Deng;Xiaolun Huang;Niraj M. Desai

  • Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants.

    James F. Markmann;Joseph W. Markmann;Dana A. Markmann;Angeles Bacquerizo

  • In situ splitting of the cadaveric liver for transplantation.

    J A Goss;H Yersiz;C R Shackleton;P Seu

  • Orthotopic Liver Transplantation for Hepatitis C: Outcome, Effect of Immunosuppression, and Causes of Retransplantation During an 8-Year Single-Center Experience

    Rafik M. Ghobrial;Douglas G. Farmer;Angeles Baquerizo;Steven Colquhoun

Frequent Co-Authors

Ali Naji
Ali Naji University of Pennsylvania
Abraham Shaked
Abraham Shaked University of Pennsylvania
Kim M. Olthoff
Kim M. Olthoff University of Pennsylvania
Ronald W. Busuttil
Ronald W. Busuttil University of California, Los Angeles
Robert J. Porte
Robert J. Porte University Medical Center Groningen
Douglas G. Farmer
Douglas G. Farmer University of California, Los Angeles
Bernhard J. Hering
Bernhard J. Hering University of Minnesota
David H. Sachs
David H. Sachs Columbia University
Andrew J. Caton
Andrew J. Caton The Wistar Institute
Mehmet Toner
Mehmet Toner Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medical careers beyond traditional MD programs, online degrees offer flexible and affordable alternatives. Specializing in fields such as nursing and healthcare administration can expand your career options and accelerate your entry into the workforce.

Advanced nursing degrees are in high demand. If you already have your BSN, you might consider bsn to np programs online, which can prepare you for nurse practitioner roles including in psychiatric-mental health. Those aiming for top clinical practice positions may explore cheap online dnp programs to earn a Doctor of Nursing Practice without the cost of traditional, on-campus study.

Healthcare administration is another in-demand field with strong growth potential. Many students search for the cheapest mha programs online and cheapest mha programs online healthcare to reduce tuition costs while qualifying for advanced leadership roles in hospitals and clinics.

Exploring these online pathways is an excellent way to build a rewarding healthcare career with the benefits of flexibility and affordability.

Best Scientists Citing James F. Markmann

Trending Scientists

Recently Published Articles